Authors:
LEMELLEDO JM
MERANI S
KOSZYCKI D
BELLAVANCE F
PALMOUR R
GUTKOWSKA J
STEINBERG S
BICHET DG
BRADWEJN J
Citation: Jm. Lemelledo et al., SENSITIVITY TO CCK-4 IN WOMEN WITH AND WITHOUT PREMENSTRUAL DYSPHORICDISORDER (PMDD) DURING THEIR FOLLICULAR AND LUTEAL PHASES, Neuropsychopharmacology, 20(1), 1999, pp. 81-91
Authors:
DEPOT M
MERANI S
BRADWEJN J
MUKHERJEE J
CAILLE J
GUTKOWSKA J
CAILLE G
Citation: M. Depot et al., EFFECT OF ORAL ONDANSETRON CAN TOTAL CHOLECYSTOKININ PLASMA-LEVELS FOLLOWING CCK-4 PANIC CHALLENGE PROCEDURE IN HEALTHY-MEN, Journal of psychiatry & neuroscience, 23(5), 1998, pp. 298-304
Citation: J. Shlik et al., DECREASE IN SHORT-TERM-MEMORY FUNCTION INDUCED BY CCK-4 IN HEALTHY-VOLUNTEERS, Peptides (New York, N.Y. 1980), 19(6), 1998, pp. 969-975
Authors:
LEMELLEDO JM
BRADWEJN J
KOSZYCKI D
BICHET DG
BELLAVANCE F
Citation: Jm. Lemelledo et al., THE ROLE OF THE BETA-NORADRENERGIC SYSTEM IN CHOLECYSTOKININ-TETRAPEPTIDE-INDUCED PANIC SYMPTOMS, Biological psychiatry, 44(5), 1998, pp. 364-366
Authors:
BRADWEJN J
LEGRAND JM
KOSZYCKI D
BATES JHT
BOURIN M
Citation: J. Bradwejn et al., EFFECTS OF CHOLECYSTOKININ TETRAPEPTIDE ON RESPIRATORY-FUNCTION IN HEALTHY-VOLUNTEERS, The American journal of psychiatry, 155(2), 1998, pp. 280-282
Authors:
SHLIK J
ALUOJA A
VASAR V
VASAR E
PODAR T
BRADWEJN J
Citation: J. Shlik et al., EFFECTS OF CITALOPRAM TREATMENT ON BEHAVIORAL, CARDIOVASCULAR AND NEUROENDOCRINE RESPONSE TO CHOLECYSTOKININ TETRAPEPTIDE CHALLENGE IN PATIENTS WITH PANIC DISORDER, Journal of psychiatry & neuroscience, 22(5), 1997, pp. 332-340
Citation: J. Shlik et al., CHOLECYSTOKININ AND PSYCHIATRIC-DISORDERS - ROLE IN ETIOLOGY AND POTENTIAL OF RECEPTOR ANTAGONISTS IN THERAPY, CNS DRUGS, 8(2), 1997, pp. 134-152
Authors:
BURROWS G
EVANS L
BAUMHACKL U
HEBENSTREIT H
KATSCHNIG H
SCHONY W
SCHOLZ H
WILMOTTE J
CAMPOS J
COSTA D
NARDI A
VERSIANI M
DASILVA A
BOWEN R
BRADWEJN J
JOHNSTON D
PLAMONDON J
STEIN M
SWINSON R
CHNEIWEISS L
BELLAIRE W
OSTERHEIDER M
SONNTAG R
COOKSON J
FREEMAN C
HIRSCH S
MULLIN J
MURRAY R
NUTT D
PETURSSON H
ODONOGHUE F
MIN J
ALLGULANDER C
ANDERSCH S
BACKA H
REALINI R
SIEGEL JL
BULLER R
KATSCHNIG H
STEIN MB
BULLER R
Citation: G. Burrows et al., MOCLOBEMIDE IN SOCIAL PHOBIA - A DOUBLE-BLIND, PLACEBO-CONTROLLED CLINICAL-STUDY, European archives of psychiatry and clinical neuroscience, 247(2), 1997, pp. 71-80
Citation: Pw. Frankland et al., ACTIVATION OF AMYGDALA CHOLECYSTOKININ(B) RECEPTORS POTENTIATES THE ACOUSTIC STARTLE RESPONSE IN THE RAT, The Journal of neuroscience, 17(5), 1997, pp. 1838-1847
Authors:
ALUOJA A
SHLIK J
VASAR V
KINGISEPP PH
JAGOMAGI K
VASAR E
BRADWEJN J
Citation: A. Aluoja et al., EMOTIONAL AND COGNITIVE-FACTORS CONNECTED WITH RESPONSE TO CHOLECYSTOKININ TETRAPEPTIDE IN HEALTHY-VOLUNTEERS, Psychiatry research, 66(1), 1997, pp. 59-67
Authors:
LEMELLEDO JM
BRADWEJN J
KOSZYCKI D
BICHET D
BELLAVANCE F
Citation: Jm. Lemelledo et al., THE ROLE OF THE BETA-ADRENERGIC SYSTEM IN BEHAVIORAL AND NEUROENDOCRINE RESPONSE TO CCK-4, Psychopharmacology bulletin, 33(3), 1997, pp. 546-546
Authors:
SHLIK J
VASAR V
ALUOJA A
KINGISEPP PH
JAGOMAGI K
VASAR E
RAGO L
BRADWEJN J
Citation: J. Shlik et al., THE EFFECT OF CHOLECYSTOKININ TETRAPEPTIDE ON RESPIRATORY RESISTANCE IN HEALTHY-VOLUNTEERS, Biological psychiatry, 42(3), 1997, pp. 206-212
Authors:
BRAWMANMINTZER O
LYDIARD RB
BRADWEJN J
VILLARREAL G
KNAPP R
EMMANUEL N
WARE MR
HE Q
BALLENGER JC
Citation: O. Brawmanmintzer et al., EFFECTS OF THE CHOLECYSTOKININ AGONIST PENTAGASTRIN IN PATIENTS WITH GENERALIZED ANXIETY DISORDER, The American journal of psychiatry, 154(5), 1997, pp. 700-702
Citation: D. Koszycki et al., INFLUENCE OF PERSONALITY ON BEHAVIORAL-RESPONSE TO CHOLECYSTOKININ-TETRAPEPTIDE IN PATIENTS WITH PANIC DISORDER, Psychiatry research, 62(2), 1996, pp. 131-138
Authors:
BRAWMANMINTZER O
LYDIARD RB
BRADWEJN J
VILLARREAL G
BOOK S
KNAPP R
EMMANUEL N
BALLENGER JC
Citation: O. Brawmanmintzer et al., SYMPTOM ENDORSEMENT IN PATIENTS WITH GENERALIZED ANXIETY DISORDER FOLLOWING PENTAGASTRIN INFUSION, Psychopharmacology bulletin, 32(3), 1996, pp. 417-417
Authors:
ZOHAR J
JUDGE R",AIT,"ALVAREZ E",ANSSEAU,"ARNOUX A
BARBIER J",BARDEL,"BARRERE J
BARTHOLOME F
BEJEROT S",BERNON,BIMES,BLAUWBLOMME,"BOLLEN J
BONNAFFOUX D
BONNETGUERIN B",BRACCINI,"CERVERA S",COSTE,COTTRAUX,"DEBLEEKER E
BRADWEJN J",DEBUCK,"DENAYER AR
DEWILDE J",DHAENEN,"DIJKSTRA H
DITZLER K
FARUCH M
FAROUX C
FREEMAN C
HAND I",HANTOUCHE,"HAZIZA L
HEALY D
KASPER S",KHALIFA,"KLEIN E
KULIK J
LEIBOVICI A",LEPINE,MARMIN,"MOLES MF
NOTE I
NOTTEN P
NUTZINGER D
ODONOGHUE F
OSTERHEIDER M
PARMENTIER G
PEETERS M
PON J
RAVINDRAN A
RAVIZZA L",SAINTMARD,"SAUER H",SERVANT,"STEIN M
STITI S
SWINSON R
VANAMERINGEN M",WILLEMSE,"WILMINK E",WILMOTTE,"WINTER R
Citation: J. Zohar et al., PAROXETINE VERSUS CLOMIPRAMINE IN THE TREATMENT OF OBSESSIVE-COMPULSIVE DISORDER, British Journal of Psychiatry, 169(4), 1996, pp. 468-474
Citation: Pw. Frankland et al., INTRACEREBROVENTRICULAR INFUSION OF THE CCKB RECEPTOR AGONIST PENTAGASTRIN POTENTIATES ACOUSTIC STARTLE, Brain research, 733(1), 1996, pp. 129-132
Authors:
KOSZYCKI D
ZACHARKO RM
LEMELLEDO JM
YOUNG SN
BRADWEJN J
Citation: D. Koszycki et al., EFFECT OF ACUTE TRYPTOPHAN DEPLETION ON BEHAVIORAL, CARDIOVASCULAR, AND HORMONAL SENSITIVITY TO CHOLECYSTOKININ-TETRAPEPTIDE CHALLENGE IN HEALTHY-VOLUNTEERS, Biological psychiatry, 40(7), 1996, pp. 648-655